Archives of CraniOrofacial Sciences

Register      Login

VOLUME 7 , ISSUE 2 ( July-December, 2024 ) > List of Articles

Original Article

Anemia in Pulmonary Tuberculosis and Treatment Outcome

Mahendra K Bharti

Keywords : Antitubercular treatment, Hemoglobin, Lost to follow-up, Pulmonary tuberculosis, Tuberculosis

Citation Information : Bharti MK. Anemia in Pulmonary Tuberculosis and Treatment Outcome. Arch Craniofac Sci 2024; 7 (2):34-36.

DOI: 10.5005/acofs-11029-0008

License: CC BY-NC 4.0

Published Online: 26-02-2025

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Introduction: Tuberculosis (TB) remains a major health problem in southeast Asia, especially in India. Persons with pulmonary tuberculosis (PTB) are commonly anemic, especially in poor low-socioeconomic population. Here, we assessed the TB treatment outcome in anemic and nonanemic TB patients. Materials and methods: A total of 302 patients more than 18 years old with confirmed PTB were included from Government Medical College-associated hospital, Datia, Madhya Pradesh, in 2023. Anemia severity (mild, moderate, and severe) based on hemoglobin (Hb) estimation. Anemia associated with unfavorable outcome (death, failure, lost to follow-up, regimen modification, or relapse), compared with treatment success (cure or treatment completion). Results: Out of 302 participants, 210 (69.53%) were anemic at baseline. Patients with moderate/severe anemia were more symptomatic and had higher frequencies of unfavorable outcomes compared with the other groups. Severe anemia was associated with unfavorable outcomes like death. Conclusion: Pulmonary TB patient with moderate to severe anemia has significant impact on antitubercular treatment (ATT) outcome and significant risk factor for death.


PDF Share
  1. World Health Organization. Global tuberculosis report 2022 [Internet]. Geneva: WHO. 2022. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022.
  2. Barreto-Duarte B, Araújo-Pereira M, Nogueira BMF, et al. Tuberculosis burden and determinants of treatment outcomes according to age in Brazil: A nationwide study of 896,314 cases reported between 2010 and 2019. Front Med (Lausanne) 2021;8:706689. DOI: 10.3389/fmed.2021.706689.
  3. Demitto FO, Araújo-Pereira M, Schmaltz CA, et al. Impact of persistent anemia on systemic inflammation and tuberculosis outcomes in persons living with HIV. Front Immunol 2020;11:588405. DOI: 10.3389/fimmu.2020.588405/full#B11.
  4. Arriaga MB, Araújo-Pereira M, Barreto-Duarte B, et al. The effect of diabetes and prediabetes on antituberculosis treatment outcomes: A multicenter prospective cohort study. J Infect Dis 2022;225(4):617–626. DOI: 10.1093/infdis/jiab427.
  5. World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity [Internet]. 2011. Available from: https://www.who.int/vmnis/indicators/haemoglobin.pdf.
  6. Barzegari S, Afshari M, Movahednia M, et al. Prevalence of anemia among patients with tuberculosis: A systematic review and meta-analysis. Indian J Tuberc 2019;66(2):299–307. DOI: 10.1016/j.ijtb.2019.04.002.
  7. Minchella PA, Donkor S, Owolabi O, et al. Complex anemia in tuberculosis: The need to consider causes and timing when designing interventions. Clin Infect Dis 2015;60(5):764–772. DOI: 10.1093/cid/ciu945.
  8. Gelaw Y, Getaneh Z, Melku M. Anemia as a risk factor for tuberculosis: A systematic review and meta-analysis. Environ Health Prev Med 2021;26(1):13. DOI: 10.1186/s12199-020-00931-z.
  9. de Mendonça EB, Schmaltz CA, Sant'Anna FM, et al. Anemia in tuberculosis cases: A biomarker of severity? [Internet]. 2021. Available from: https://www.arca.fiocruz.br/handle/icict/46402.
  10. Araújo-Pereira M, Barreto-Duarte B, Arriaga MB, et al. Relationship between anemia and systemic inflammation in people living with HIV and tuberculosis: A sub-analysis of the CADIRIS clinical trial. Front Immunol 2022;13:916216. DOI: 10.3389/fimmu.2022.916216.
  11. Gil-Santana L, Cruz LAB, Arriaga MB, et al. Tuberculosis-associated anemia is linked to a distinct inflammatory profile that persists after initiation of antitubercular therapy. Sci Rep 2019;9(1):1381. DOI: 10.1038/s41598-018-37860-5.
  12. World Health Organization. Meeting report of the WHO expert consultation on drug-resistant tuberculosis treatment outcome definitions [Internet]. 2020. Available from: https://www.who.int/publications-detail-redirect/9789240022195.
  13. Oliveira M, Delogo K, Oliveira H, et al. Anemia in hospitalized patients with pulmonary tuberculosis. J Bras Pneumol 2014;40:403–410. DOI: 10.1590/S1806-37132014000400008.
  14. Lee S, Kang Y, Lee S, et al. The prevalence and evolution of anemia associated with tuberculosis. J Korean Med Sci 2006;21:1028–1032. DOI: 10.3346/jkms.2006.21.6.1028.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.